close
close

Two Florida Democrats warn that Medicare drug price cuts are at risk if Harris doesn't win • Florida Phoenix

As a state with one of the largest senior populations, Florida is a “super beneficiary” of the Biden administration's Medicare drug pricing negotiations, Democratic U.S. Rep. Debbie Wasserman Schultz of South Florida said during a press conference organized by the Harris-Walz campaign on Friday.

Wasserman Schultz and Democratic Congressman Maxwell Frost of the Orlando area praised the $6 billion in projected savings on 10 drugs announced by the White House on Thursday. However, the savings from the Inflation Reduction Act (IRA) of 2022 will not take effect until January 2026.

Democratic lawmakers said the only way to convince people of these savings is for Vice President Kamala Harris to defeat Donald Trump in November.

U.S. Rep. Debbie Wasserman Schultz (D-FL). (Photo by Anna Moneymaker/Getty Images)
Maxwell Frost. Photo credit: U.S. House of Representatives

“There is no guarantee that our retirees will be able to keep the money because if Trump wins in November, he and JD Vance's Project 2025 would repeal the Inflation Control Act,” Wasserman Schultz said.

“It's there in black and white and it goes even further by repealing Obamacare, driving up premiums and health care costs and allowing insurance companies to once again deny you care because you have a pre-existing condition. Trump in the White House is basically a nightmare for our seniors who need prescription drugs and need them to be available and affordable.”

Similar press conferences with state and congressional representatives were held in states such as Wisconsin, North Carolina, Nevada, Georgia and Pennsylvania.

Project 2025, a presidential transition plan developed by the conservative think tank Heritage Foundation, calls for repealing the IRA's health care policy, but Trump's campaign is trying to distance itself from the project, which was created by people in his first administration. Trump, however, has been critical of the IRA's tax credit policy for renewable energy.

Earlier Friday, Harris unveiled her plan to speed up Medicare drug negotiations and raise the cap on Medicare insulin payments from $35 a month and the maximum out-of-pocket costs for other prescription drugs to $2,000.

While Democrats celebrate capping deductibles at $2,000, the federal government must pay billions to private insurance companies that want to raise their premiums to cover the additional cost of drugs, Politico reports.

Wasserman Schultz dodged a question from a Politico reporter about whether the IRA needs to be revised to prevent future premium spikes.